Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Mattsson

Showing results (61-70 of 258) with videos related to

Pageof 26
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 24, 2018
Norovirus causing severe gastrointestinal disease following allogeneic hematopoietic stem cell transplantation: A retrospective analysisLisa Swartling, Per Ljungman, Mats Remberger, et al.
Transplantation|October 10, 2018
The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Inherited Diseases Is Influenced by HLA Match, Year of Transplantation, and Immunized Female DonorOlle Ringden, Mats Remberger, Britt Gustafsson, et al.
Stem Cell Reviews and Reports|July 23, 2020
Treatment of COVID-19 Pneumonia: the Case for Placenta-derived Cell TherapyEkaterine Berishvili, Laurent Kaiser, Marie Cohen, et al.
Bone Marrow Transplantation|February 7, 2019
T-cell frequencies of CD8<sup>+</sup> γδ and CD27<sup>+</sup> γδ cells in the stem cell graft predict the outcome after allogeneic hematopoietic cell transplantationAhmed Gaballa, Arwen Stikvoort, Björn Önfelt, et al.
Transplantation|March 30, 2002
Clinical tolerance after allogeneic hematopoietic stem cell transplantation: a study of influencing factorsPatrik Hentschke, Mats Remberger, Jonas Mattsson, et al.
Bone Marrow Transplantation|June 25, 2022
Acute kidney injury within 100 days post allogeneic hematopoietic cell transplantation is associated with increased risk of post-transplant complications and poor transplant outcomesKayla Madsen, Karyne Pelletier, Gabrielle Côté, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 4, 2020
Real-world study of direct medical and indirect costs and time spent in healthcare in patients with chronic graft versus host diseaseFrida Schain, Nurgul Batyrbekova, Johan Liwing, et al.
European Journal of Haematology|July 7, 2012
Treatment with mesenchymal stromal cells is a risk factor for pneumonia-related death after allogeneic hematopoietic stem cell transplantationUlrica Forslöw, Ola Blennow, Katarina LeBlanc, et al.
Clinical Immunology (Orlando, Fla.)|March 6, 2012
Expansion of T-cells from the cord blood graft as a predictive tool for complications and outcome of cord blood transplantationJens Gertow, Sofia Berglund, Mantas Okas, et al.
Transfusion|May 14, 2015
Quality of the hematopoietic stem cell graft affects the clinical outcome of allogeneic stem cell transplantationEmma Watz, Mats Remberger, Olle Ringden, et al.
Pageof 26

Showing results (61-70 of 258) with videos related to

Sort By:
Pageof 26
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 24, 2018
Norovirus causing severe gastrointestinal disease following allogeneic hematopoietic stem cell transplantation: A retrospective analysisLisa Swartling, Per Ljungman, Mats Remberger, et al.
Transplantation|October 10, 2018
The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Inherited Diseases Is Influenced by HLA Match, Year of Transplantation, and Immunized Female DonorOlle Ringden, Mats Remberger, Britt Gustafsson, et al.
Stem Cell Reviews and Reports|July 23, 2020
Treatment of COVID-19 Pneumonia: the Case for Placenta-derived Cell TherapyEkaterine Berishvili, Laurent Kaiser, Marie Cohen, et al.
Bone Marrow Transplantation|February 7, 2019
T-cell frequencies of CD8<sup>+</sup> γδ and CD27<sup>+</sup> γδ cells in the stem cell graft predict the outcome after allogeneic hematopoietic cell transplantationAhmed Gaballa, Arwen Stikvoort, Björn Önfelt, et al.
Transplantation|March 30, 2002
Clinical tolerance after allogeneic hematopoietic stem cell transplantation: a study of influencing factorsPatrik Hentschke, Mats Remberger, Jonas Mattsson, et al.
Bone Marrow Transplantation|June 25, 2022
Acute kidney injury within 100 days post allogeneic hematopoietic cell transplantation is associated with increased risk of post-transplant complications and poor transplant outcomesKayla Madsen, Karyne Pelletier, Gabrielle Côté, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 4, 2020
Real-world study of direct medical and indirect costs and time spent in healthcare in patients with chronic graft versus host diseaseFrida Schain, Nurgul Batyrbekova, Johan Liwing, et al.
European Journal of Haematology|July 7, 2012
Treatment with mesenchymal stromal cells is a risk factor for pneumonia-related death after allogeneic hematopoietic stem cell transplantationUlrica Forslöw, Ola Blennow, Katarina LeBlanc, et al.
Clinical Immunology (Orlando, Fla.)|March 6, 2012
Expansion of T-cells from the cord blood graft as a predictive tool for complications and outcome of cord blood transplantationJens Gertow, Sofia Berglund, Mantas Okas, et al.
Transfusion|May 14, 2015
Quality of the hematopoietic stem cell graft affects the clinical outcome of allogeneic stem cell transplantationEmma Watz, Mats Remberger, Olle Ringden, et al.
Pageof 26